Nifurant-100 SR Tablet

Nitrofurantoin 100 mg Sustained Release Tablets — UTI Antibiotic

Nifurant-100 SR Tablet — Nitrofurantoin 100 mg (Sustained Release) from Trumac Healthcare PCD Pharma Franchise India

Composition Nitrofurantoin 100 mg (Sustained Release)
Dosage Form Sustained Release Tablet
Pack Type Alu-Alu Blister
Pack Size 10 x 10 Tablets
MRP ₹ 907
Therapy G.P. / Urology / Gynaecology — Urinary Tract Antibacterial
Storage Store below 30 °C in a dry place, protected from light and moisture.

📱 WhatsApp Enquiry📞 Call: +919041677932

About Nifurant-100 SR Tablet

Nifurant-100 SR Tablet contains Nitrofurantoin 100 mg in SR form — first-line antibiotic for uncomplicated lower UTI (cystitis) per WHO and IDSA guidelines. Concentrates in urine to bactericidal levels with minimal resistance after 50+ years of use.

SR formulation allows twice-daily dosing vs four-times daily for immediate-release. Preferred over Fluoroquinolones for uncomplicated UTI due to lower collateral resistance.

Manufactured by Trumac Healthcare under WHO-GMP. Available for monopoly-based PCD pharma franchise and third-party manufacturing.

Indications

  • Uncomplicated lower UTI (cystitis)
  • Recurrent UTI prophylaxis
  • Asymptomatic bacteriuria in pregnancy (selected)
  • Long-term UTI prophylaxis (CKD, immunosuppression)

Mechanism of Action

Nitrofurantoin is activated by bacterial nitroreductase to reactive intermediates that damage bacterial DNA, ribosomes, and metabolic enzymes. Concentrates 50x in urine vs serum — making it ineffective for pyelonephritis but excellent for cystitis. Low CRR (collateral resistance).

Dosage & Administration

Adults: 100 mg SR twice daily x 5–7 days for UTI; 50–100 mg at bedtime for prophylaxis.

Side Effects

Nausea, GI upset (take with food), pulmonary toxicity (acute hypersensitivity + chronic interstitial pneumonitis with long-term use), peripheral neuropathy, hepatotoxicity (rare).

Contraindications & Precautions

Renal impairment (CrCl <30 ml/min — accumulates), G6PD deficiency, pregnancy at term (38–42 weeks), infants <1 month, pyelonephritis.

Storage

Store below 30 °C in a dry place, protected from light and moisture.

PCD Pharma Franchise & Third-Party Manufacturing
Nifurant-100 SR Tablet is available for monopoly-based PCD pharma franchise across India and for third-party manufacturing under your brand. WHO-GMP certified, with full visual-aid and promotional support. Become a Trumac franchise partner →

Frequently Asked Questions

What is Nifurant-100 SR Tablet used for?

Nifurant-100 SR Tablet contains Nitrofurantoin 100 mg (Sustained Release). Used as per the indications described above.

How should Nifurant-100 SR Tablet be taken?

As directed by your physician. Complete the prescribed course.

Is Nifurant-100 SR Tablet available for PCD pharma franchise?

Yes, Trumac Healthcare offers Nifurant-100 SR Tablet on monopoly-based PCD pharma franchise and for third-party manufacturing.

How should Nifurant-100 SR Tablet be stored?

Store below 30 °C in a dry place, protected from light and moisture.

Is Nifurant-100 SR Tablet WHO-GMP certified?

Yes, manufactured in WHO-GMP and DCGI-compliant facilities.

Related Products

B2B Disclaimer: This page is part of a Business-to-Business (B2B) pharmaceutical catalog intended for distributors, PCD franchise partners and healthcare professionals. Information provided is for commercial and educational reference only. Not for consumer sale. Patients must not self-medicate; please consult a qualified medical practitioner. All trade inquiries are subject to valid Drug License and GST documentation.